Industry: Medical Care
Published Date: 2026-07-18
Pages: 144 Pages
Report ld: 5588249
Request Sample
Customized Report
Adeno-Associated Virus (AAV) Packaging Service Market Size(US$)

CAGR 2026-2032
11.1%
Market Size,2032
USD 2,627
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Adeno-Associated Virus (AAV) Packaging Service market was valued at US$ 1249 million in 2025 and is anticipated to reach US$ 2627 million by 2032, at a CAGR of 11.1% from 2026 to 2032.
Adeno-associated virus (AAV) packaging services refer to customized development and manufacturing activities in which a customer-provided or jointly designed ITR-containing construct is packaged into a recombinant AAV vector carrying a gene of interest, gene-silencing sequence, gene-editing component or reporter gene. The service workflow generally includes vector design and construction, plasmid preparation, cell culture and transfection, vector harvest, purification, concentration, aliquoting and quality testing, covering research-grade, preclinical-grade and GMP-grade projects. Key upstream inputs include transfer plasmids, Rep/Cap plasmids, helper plasmids, HEK293 or Sf9 cells, culture media, transfection reagents, nucleases, chromatography resins, filtration consumables and analytical reagents. Major downstream customers include universities, research institutes, hospital research platforms, gene therapy developers, biotechnology companies, pharmaceutical companies and CROs, with applications spanning basic research, animal studies, preclinical evaluation, IND submissions, clinical development and commercial manufacturing. The industry's overall gross margin is generally estimated at approximately 32%-48%.
The global market consists of research-grade packaging providers, specialized AAV CROs, integrated cell and gene therapy CDMOs and large biopharmaceutical service groups operating dedicated AAV platforms. Research-grade projects are numerous, relatively short and fragmented, with competition centered on serotype coverage, titer, purity, turnaround time and price. Preclinical and GMP programs are less frequent but require considerably greater investment in process scale-up, analytical methods, batch consistency, quality systems and regulatory documentation. Providers capable of maintaining process continuity from vector design and small-scale packaging through GMP and commercial manufacturing generally develop stronger customer retention, particularly after a program enters clinical development.
Demand is supported by gene-function research, rare-disease and neurological gene therapy, engineered-capsid screening, gene-editing delivery and greater outsourcing by biotechnology companies. Different AAV capsids enable gene delivery to the eye, liver, central nervous system, muscle and other tissues, while dual- and multi-vector systems extend the technology to larger or more complex payloads. The FDA's 2026 approval of the first dual-AAV gene therapy for inherited hearing loss demonstrates the continued expansion of AAV into new vector configurations and therapeutic areas, supporting demand for dual-vector development, analytics and scalable manufacturing.
Adherent HEK293 triple-plasmid transfection remains widely used for research and smaller programs, while suspension HEK293 systems have become the principal route for clinical and commercial scale-up. Baculovirus-Sf9 systems are used in selected large-scale processes. Stable producer-cell lines, dual-plasmid systems and plasmid-reduced technologies are being developed to lower raw-material costs and improve consistency. Downstream competition is moving beyond vector-genome titer toward full-capsid enrichment, genome-integrity control and tighter reduction of host-cell proteins, residual DNA, residual plasmids and replication-competent AAV.
The principal constraints include gene therapy financing and pipeline reprioritization, high clinical attrition, underutilized GMP facilities, elevated manufacturing costs and the immunological and safety limitations of AAV. Serious liver-related safety events led the FDA to restrict the use of a major AAV gene therapy in 2025, increasing the focus on dose selection, impurity control, clinical monitoring and long-term follow-up. At the same time, the FDA introduced a more flexible approach to certain cell and gene therapy CMC requirements in 2026, which may help selected rare-disease programs progress more efficiently but does not reduce expectations for identity, potency, purity and manufacturing consistency.
This report delivers a comprehensive overview of the global Adeno-Associated Virus (AAV) Packaging Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Adeno-Associated Virus (AAV) Packaging Service. The Adeno-Associated Virus (AAV) Packaging Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Adeno-Associated Virus (AAV) Packaging Service market comprehensively. Regional market sizes by Type, by Application, by Service Scope, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Adeno-Associated Virus (AAV) Packaging Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Service Scope, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Adeno-Associated Virus (AAV) Packaging Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Research Grade
1.2.3 Preclinical Grade
1.2.4 GMP Grade
1.3 Market by Service Scope
1.3.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Service Scope: 2021 vs 2025 vs 2032
1.3.2 Packaging Only
1.3.3 Vector Construction and Packaging
1.3.4 End-to-End Development and Manufacturing
1.4 Market by Production Platform
1.4.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Production Platform: 2021 vs 2025 vs 2032
1.4.2 Adherent HEK293
1.4.3 Suspension HEK293
1.4.4 Baculovirus-Sf9
1.4.5 Other
1.5 Market by Application
1.5.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Academic and Research Institutions
1.5.3 Biotechnology Companies
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Perspective (2021–2032)
2.2 Global Adeno-Associated Virus (AAV) Packaging Service Growth Trends by Region
2.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Adeno-Associated Virus (AAV) Packaging Service Historic Market Size by Region (2021–2026)
2.2.3 Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Region (2027–2032)
2.3 Adeno-Associated Virus (AAV) Packaging Service Market Dynamics
2.3.1 Adeno-Associated Virus (AAV) Packaging Service Industry Trends
2.3.2 Adeno-Associated Virus (AAV) Packaging Service Market Drivers
2.3.3 Adeno-Associated Virus (AAV) Packaging Service Market Challenges
2.3.4 Adeno-Associated Virus (AAV) Packaging Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adeno-Associated Virus (AAV) Packaging Service Players by Revenue
3.1.1 Global Top Adeno-Associated Virus (AAV) Packaging Service Players by Revenue (2021–2026)
3.1.2 Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Adeno-Associated Virus (AAV) Packaging Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Adeno-Associated Virus (AAV) Packaging Service Revenue
3.4 Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration Ratio
3.4.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adeno-Associated Virus (AAV) Packaging Service Revenue in 2025
3.5 Global Key Players of Adeno-Associated Virus (AAV) Packaging Service Head Offices and Areas Served
3.6 Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Products and Applications
3.7 Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Adeno-Associated Virus (AAV) Packaging Service Breakdown Data by Type
4.1 Global Adeno-Associated Virus (AAV) Packaging Service Historic Market Size by Type (2021–2026)
4.2 Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Type (2027–2032)
5 Adeno-Associated Virus (AAV) Packaging Service Breakdown Data by Application
5.1 Global Adeno-Associated Virus (AAV) Packaging Service Historic Market Size by Application (2021–2026)
5.2 Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)
6.2 North America Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2021–2026)
6.4 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)
7.2 Europe Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2021–2026)
7.4 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)
8.2 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)
9.2 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2021–2026)
9.4 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)
10.2 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Introduction
11.1.4 Thermo Fisher Scientific Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Adeno-Associated Virus (AAV) Packaging Service Introduction
11.2.4 Lonza Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.2.5 Lonza Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Introduction
11.3.4 Charles River Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.3.5 Charles River Laboratories Recent Development
11.4 Catalent
11.4.1 Catalent Company Details
11.4.2 Catalent Business Overview
11.4.3 Catalent Adeno-Associated Virus (AAV) Packaging Service Introduction
11.4.4 Catalent Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.4.5 Catalent Recent Development
11.5 AGC Biologics
11.5.1 AGC Biologics Company Details
11.5.2 AGC Biologics Business Overview
11.5.3 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Introduction
11.5.4 AGC Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.5.5 AGC Biologics Recent Development
11.6 SK pharmteco
11.6.1 SK pharmteco Company Details
11.6.2 SK pharmteco Business Overview
11.6.3 SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Introduction
11.6.4 SK pharmteco Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.6.5 SK pharmteco Recent Development
11.7 OXB
11.7.1 OXB Company Details
11.7.2 OXB Business Overview
11.7.3 OXB Adeno-Associated Virus (AAV) Packaging Service Introduction
11.7.4 OXB Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.7.5 OXB Recent Development
11.8 Forge Biologics
11.8.1 Forge Biologics Company Details
11.8.2 Forge Biologics Business Overview
11.8.3 Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Introduction
11.8.4 Forge Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.8.5 Forge Biologics Recent Development
11.9 Viralgen
11.9.1 Viralgen Company Details
11.9.2 Viralgen Business Overview
11.9.3 Viralgen Adeno-Associated Virus (AAV) Packaging Service Introduction
11.9.4 Viralgen Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.9.5 Viralgen Recent Development
11.10 Andelyn Biosciences
11.10.1 Andelyn Biosciences Company Details
11.10.2 Andelyn Biosciences Business Overview
11.10.3 Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Introduction
11.10.4 Andelyn Biosciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.10.5 Andelyn Biosciences Recent Development
11.11 Revvity
11.11.1 Revvity Company Details
11.11.2 Revvity Business Overview
11.11.3 Revvity Adeno-Associated Virus (AAV) Packaging Service Introduction
11.11.4 Revvity Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.11.5 Revvity Recent Development
11.12 Virovek
11.12.1 Virovek Company Details
11.12.2 Virovek Business Overview
11.12.3 Virovek Adeno-Associated Virus (AAV) Packaging Service Introduction
11.12.4 Virovek Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.12.5 Virovek Recent Development
11.13 Fortis Life Sciences
11.13.1 Fortis Life Sciences Company Details
11.13.2 Fortis Life Sciences Business Overview
11.13.3 Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Introduction
11.13.4 Fortis Life Sciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.13.5 Fortis Life Sciences Recent Development
11.14 SignaGen Laboratories
11.14.1 SignaGen Laboratories Company Details
11.14.2 SignaGen Laboratories Business Overview
11.14.3 SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Introduction
11.14.4 SignaGen Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.14.5 SignaGen Laboratories Recent Development
11.15 Applied Biological Materials
11.15.1 Applied Biological Materials Company Details
11.15.2 Applied Biological Materials Business Overview
11.15.3 Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Introduction
11.15.4 Applied Biological Materials Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.15.5 Applied Biological Materials Recent Development
11.16 Takara Bio
11.16.1 Takara Bio Company Details
11.16.2 Takara Bio Business Overview
11.16.3 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Introduction
11.16.4 Takara Bio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.16.5 Takara Bio Recent Development
11.17 VectorBuilder
11.17.1 VectorBuilder Company Details
11.17.2 VectorBuilder Business Overview
11.17.3 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Introduction
11.17.4 VectorBuilder Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.17.5 VectorBuilder Recent Development
11.18 GenScript ProBio
11.18.1 GenScript ProBio Company Details
11.18.2 GenScript ProBio Business Overview
11.18.3 GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Introduction
11.18.4 GenScript ProBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.18.5 GenScript ProBio Recent Development
11.19 PackGene Biotech
11.19.1 PackGene Biotech Company Details
11.19.2 PackGene Biotech Business Overview
11.19.3 PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Introduction
11.19.4 PackGene Biotech Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.19.5 PackGene Biotech Recent Development
11.20 OBiO Technology
11.20.1 OBiO Technology Company Details
11.20.2 OBiO Technology Business Overview
11.20.3 OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Introduction
11.20.4 OBiO Technology Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.20.5 OBiO Technology Recent Development
11.21 Porton Advanced
11.21.1 Porton Advanced Company Details
11.21.2 Porton Advanced Business Overview
11.21.3 Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Introduction
11.21.4 Porton Advanced Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.21.5 Porton Advanced Recent Development
11.22 HanBio
11.22.1 HanBio Company Details
11.22.2 HanBio Business Overview
11.22.3 HanBio Adeno-Associated Virus (AAV) Packaging Service Introduction
11.22.4 HanBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
11.22.5 HanBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1249 million in 2025 to US$ 2627 million by 2032, at a CAGR of 11.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 161
USD 4900.00
(Single User License)
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1249 million in 2025 and is forecast to reach a readjusted size of US$ 2627 million by 2032 with a CAGR of 11.1% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 149
USD 4250.00
(Single User License)
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1249 million in 2025 and is projected to reach US$ 2627 million, growing at a CAGR of 11.1% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 153
USD 3950.00
(Single User License)
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 107
USD 4250.00
(Single User License)
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1390 million in 2024 to US$ 2488 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 147
USD 4900.00
(Single User License)
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 122
USD 3950.00
(Single User License)
The global market for Adeno-Associated Virus (AAV) Packaging Service was valued at US$ 1390 million in the year 2024 and is projected to reach a revised size of US$ 2488 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published Date: 2025-03-12
Pages: 98
USD 2900.00
(Single User License)
The global Adeno-Associated Virus (AAV) Packaging Service revenue was US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 125
USD 4350.00
(Single User License)
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 125
USD 3950.00
(Single User License)
Valued at US$ 1390 million in 2024, the global Adeno-Associated Virus (AAV) Packaging Service market is forecast to reach US$ 2305 million by 2030, at a CAGR of 8.8% during the forecast period.
Published Date: 2025-01-01
Pages: 159
USD 4900.00
(Single User License)
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1249 million in 2025 to US$ 2627 million by 2032, at a CAGR of 11.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 161
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1249 million in 2025 and is forecast to reach a readjusted size of US$ 2627 million by 2032 with a CAGR of 11.1% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 149
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1249 million in 2025 and is projected to reach US$ 2627 million, growing at a CAGR of 11.1% from 2026 to 2032.
Published: 2026-07-18
Pages: 153
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 107
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1390 million in 2024 to US$ 2488 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 147
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 122
The global market for Adeno-Associated Virus (AAV) Packaging Service was valued at US$ 1390 million in the year 2024 and is projected to reach a revised size of US$ 2488 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published: 2025-03-12
Pages: 98
The global Adeno-Associated Virus (AAV) Packaging Service revenue was US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published: 2025-01-01
Pages: 125
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 125
Valued at US$ 1390 million in 2024, the global Adeno-Associated Virus (AAV) Packaging Service market is forecast to reach US$ 2305 million by 2030, at a CAGR of 8.8% during the forecast period.
Published: 2025-01-01
Pages: 159
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now